Skip to content

Effect of Kutnatadi Taila and Malatyadi Taila in patchy baldness disease.

INDRALUPTA - A COMPARATIVE CLINICAL STUDY WITH KUTNATADI TAILA AND MALATYADI TAILA

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/10/037023
Enrollment
60
Registered
2021-10-01
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

Interventions

None listed

Sponsors

GOVT AYURVEDIC COLLEGE PATNA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a. Patient willing for the research trial. b. An elaborate proforma incorporating all the points of history taking and physical examination mentioned in Ayurveda as well as in modern medicine will be prepared.Each suspected patient was examined on the basis of this proforma where in each patient complete history,sign & symptoms, Dashvidh pariksha etc willbe taken.All the vital signs like blood pressure,pulse,respiration rate etc will be monitored keenly in each patient. c. Patients between age group of 8 to 50 years are included in research without any bar of caste,sex, religion and occupation. In case of Patient having age less than 18 year,consent will be taken by his Gurdian/Parent. d. In patient of multiple bald patches, each patch is considerd as separateentity and the average of all will be taken in to consideration for data collection.

Exclusion criteria

Exclusion criteria: a.Patient whose age is less than 8 years and more than 50 years. b.Patients are not willing for trial and support. c.Patients having severe disease like AIDS,Cancer, Diabetes,T.B, Severe Heart disease, Jaundice,Renal faliure,Anxiety disorder. d.Patients who have been diagnosed to have similar but other hair disease like Alopecia totalis, Alopecia universals, Androgenic alopecia etc.

Design outcomes

Primary

MeasureTime frame
.Percentage growth of hair in affected area is taken as the main parameter for assessment of therapyTimepoint: Follow up will be taken on day 7,14,21,28 with drug application & thenafter follow up will be taken without drug

Secondary

MeasureTime frame
.Photographic record of bald patches on scalp will be taken before and during follow up of research to analyze the improvement in disease conditionTimepoint: Follow up will be taken on day 7,14,21,28 with drug application & thenafter follow up will be taken without drug

Countries

India

Contacts

Public ContactJAI KUMAR SINGH

GOVT. AYURVEDIC COLLEGE & HOSPITAL,PATNA

jai.kumar1966@rediffmail.com9199373517

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026